Argos Therapeutics to Participate in 2016 EORTC-AACR-NCI Symposium
Nov 29, 2016 13:01 pm UTC| Business
DURHAM, N.C., Nov. 29, 2016 -- Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis®...
Nov 29, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Nov. 29, 2016 -- Dimension Therapeutics, Inc. (NASDAQ:DMTX), a biopharmaceutical company advancing novel, adeno-associated virus (AAV) gene therapies targeting the liver, a key organ for human...
Voyager Therapeutics and REGENXBIO Announce Exercise of Options for Rights to NAV Vectors
Nov 29, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., and ROCKVILLE, Md., Nov. 29, 2016 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous...
Newest Bullion Coin Launches To Much Fanfare
Nov 29, 2016 13:00 pm UTC| Business
LUTZ, Fla., Nov. 29, 2016 -- Gainesville Coins LLC, one of the nation's largest precious metal dealers, is introducing an exclusive new product, the 2017 1 oz Guardian Angel Silver Coin. Struck as legal tender coins for...
Bioblast Pharma Reports Third Quarter 2016 Financial Results
Nov 29, 2016 13:00 pm UTC| Business
TEL AVIV, Israel, Nov. 29, 2016 -- Bioblast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company, today announced financial results for the third quarter ended September 30, 2016. ...
Nov 29, 2016 13:00 pm UTC| Business
- Part A of the trial will evaluate three doses of I.V. CR845 versus placebo in 160 dialysis patients -- Top-line data expected in first quarter of 2017 - STAMFORD, Conn., Nov. 29, 2016 -- Cara Therapeutics, Inc....
Nov 29, 2016 13:00 pm UTC| Business
NIH Analysis of Data from Celsion’s HEAT Study Reaffirms Correlation Between Increased RFA Burn Time per Tumor Volume and Significant Improvements in Overall Survival Prior Subgroup Analysis of HEAT Study by Celsion...